Skip to main content
NATR
NASDAQ Life Sciences

EVP & President, Asia Sells $377K in Open Market Shares

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Food & Beverage Stocks · Consumer
Sentiment info
Negative
Importance info
7
Price
$23.99
Mkt Cap
$420.007M
52W Low
$11.01
52W High
$28.14
52W Position info
118% above low
Off High info
15% below high
Rel. Volume info
0.9× avg
Market data snapshot near publication time

NATR has more than doubled off its 52-week low of $11.01.

Summary

Norman Daniel C, EVP & President, Asia at Nature's Sunshine Products, reported an open market sale of $377,191 in common shares and a gift of $88,409.


Key Events · Ownership and Investor Activity · NATR

  • Key Executive Sells Shares

    Norman Daniel C, EVP & President, Asia, disposed of 15,383 common shares in an open market sale for $377,191.16 at an average price of $24.52 per share on March 13, 2026.

  • Gift Transaction Reported

    Additionally, Mr. Norman reported a gift of 3,610 shares valued at $88,408.90, further reducing his direct holdings.

  • Follows Strong Earnings Report

    This insider selling activity occurs shortly after Nature's Sunshine Products reported strong full-year 2025 financial results on March 10, 2026, with significant increases in net sales and net income.


Analysis · NATR · Life Sciences

The open market sale of $377,191 in common shares by Norman Daniel C, a key executive serving as EVP & President of Asia, is a notable insider disposition. While a portion of the total shares disposed of was a gift, the direct sale of stock by a high-ranking officer can be interpreted by investors as a signal, even if it's for personal liquidity. This transaction follows the company's recent strong financial performance reported on March 10, 2026, which highlighted increased net sales and net income. Investors will likely consider this sale in the context of the company's recent positive results and the insider's overall holdings.

At the time of this filing, NATR was trading at $23.99 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $420M. The 52-week trading range was $11.01 to $28.14. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

NATR - Latest Insights

NATR
May 11, 2026, 8:53 AM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $24.23
Real-time Price: $20.74 info
Change: -$3.49 (-14%) info
Market Cap: $364.71M info
NATR
May 11, 2026, 8:46 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $24.23
Real-time Price: $20.74 info
Change: -$3.49 (-14%) info
Market Cap: $364.71M info
NATR
May 07, 2026, 5:19 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $27.83
Real-time Price: $20.74 info
Change: -$7.09 (-25%) info
Market Cap: $364.71M info
NATR
May 07, 2026, 5:13 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $27.83
Real-time Price: $20.74 info
Change: -$7.09 (-25%) info
Market Cap: $364.71M info
NATR
May 07, 2026, 4:05 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $24.42
Real-time Price: $20.74 info
Change: -$3.68 (-15%) info
Market Cap: $364.71M info